(lp0
S'Anthera Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 15 Equities.com - 11 hours ago Anthera Pharmaceuticals Inc.  traded on unusually high volume on Mar. 15, as the stock lost 2.46% to close at $0.40. On the day, Anthera Pharmaceuticals Inc. saw 4.18 million shares trade hands on 6,735 trades. Considering that the stock averages&nbsp;...Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock and ... - NasdaqAnthera Pharma  Plans Offering of Common Stock and Warrants - StreetInsider.com'
p1
aS'Anthera Pharmaceuticals Inc.  Settles Into New 52-Week Low on March 15 ... Equities.com - 11 hours ago Shares of Anthera Pharmaceuticals Inc.  sank into a new 52-week low yesterday, and could be a company to watch at the open.'
p2
aS'ANTHERA PHARMACEUTICALS, INC.  Files An 8-K Results of Operations ... Market Exclusive - Feb 27, 2017 Anthera Pharmaceuticals, Inc.  is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases.Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Arrowhead ... - PR Newswire '
p3
aS'BRIEF-Sabby Management LLC reports 8.06 pct passive stake in Anthera ... Reuters - 15 hours ago NEW YORK, March 15 Markets are emboldened by the tone of monetary policymakers following an interest rate hike on Wednesday, but now is not the time to take on more risk in U.S.'
p4
aS'Anthera Pharmaceuticals Inc : Ignore The Lawsuits Insider Financial - Feb 23, 2017 Levi &amp; Korsinsky, Lifshitz &amp; Miller, Bronstein, Gewirtz &amp; Grossman, Johnson &amp; Weaver - just some of the LLPs flooding the PR streams for Anthera Pharmaceuticals Inc  at the major financial news outlets. Every one of these companies claims&nbsp;...Anthera Pharmaceuticals Inc.  Moves Lower on Volume Spike for February 23 - Equities.com'
p5
aS'Anthera Pharma  Prices $15M Offering of Common Stock and Warrants StreetInsider.com - Mar 14, 2017 Anthera Pharmaceuticals, Inc.  today announced the pricing of an underwritten public offering of 30,000,000 shares of its common stock at a price of $0.50 per share and two tranches of warrants to purchase an aggregate of 60,000,000 ...'
p6
aS'IMPORTANT ANTHERA PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler ... GlobeNewswire  - Feb 24, 2017 INVESTOR ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of purchasers of Anthera Pharmaceuticals, Inc.'
p7
aS'Watching Technical Positions on Anthera Pharmaceuticals Inc  Rives Journal - 15 hours ago Traders may be trying to figure out whether it is a good time to enter or exit a position in Anthera Pharmaceuticals Inc .'
p8
aS'Anthera Pharmaceuticals Inc.  Plunges 8.39% on March 03 Equities.com - Mar 3, 2017 Anthera Pharmaceuticals Inc.  had a rough trading day for Friday March 03 as shares tumbled 8.39%, or a loss of $-0.0586 per share, to close at $0.64.'
p9
aS'Anthera Pharmaceuticals Inc.  Plunges 5.29% on March 02 Equities.com - Mar 2, 2017 Anthera Pharmaceuticals Inc.  had a rough trading day for Thursday March 02 as shares tumbled 5.29%, or a loss of $-0.039 per share, to close at $0.70.Anthera Pharmaceuticals, Inc.  Insider Ownership stands at 0.1 - The Newburgh PressCan the next move of Anthera Pharmaceuticals, Inc.  be predicted? - The Oracle Examiner'
p10
a.